Desidustat in the Management of COVID-19 Patients
NCT04463602
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Desidustat
OTHER:
Standard of Care
Sponsor
Zydus Lifesciences Limited